2023 Nurse's Drug Handbook

2023 Nurses Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a straightforward style with approachable terminology, it offers concise and consistently formatted drug entries organized alphabetically. The 2023 Nurses Drug Handbook includes: Index of all generic, trade, and alternate drug names Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule Indications and dosages, as well as route, onset, peak, and duration information Incompatibilities and contraindications Interactions with drugs, food, and activities Adverse reactions Nursing considerations, including key teaching points for patients Mechanism-of-action illustrations Warnings and precautions Updated appendices, including Uncommon Drugs Bolded life-threatening Adverse Drug Reactions (ADRs) New drugs added to the 2023 Nurses Drug Handbook include: Aducanumab-avwa, Atogepant, Baricitini, Cabotegravi, Dasiglucagon, Difelikefalin, Evinacumab-dgnb, Finerenone, Ibrexafungerp, Inclisiran, Molnupiravir, Nirmatrelvir, Ponesimod, Tezepelumab-ekko, Tralokinumab-ldrm, Vericiguat.